Načítá se...
Mitochondrial hyperactivity as a potential therapeutic target in Parkinson’s disease
Mitochondrial dysfunction is thought to contribute to neurodegeneration in Parkinson’s disease (PD), yet the cellular events that lead to mitochondrial disruption remain unclear. Post-mortem studies of PD patient brains and the use of complex I inhibitors to model the disease previously suggested a...
Uloženo v:
| Vydáno v: | Transl Med Aging |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7653964/ https://ncbi.nlm.nih.gov/pubmed/33178902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tma.2020.07.007 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|